|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
36,440,000 |
Market
Cap: |
347.64(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$9.54 - $9.54 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile SeaSpine Holdings is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. Co. has a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system to perform fusion procedures in the lumbar, thoracic and cervical spine. Co.'s orthobiologics products consist of a range of bone graft substitutes including spine, hip, and extremities procedures. Co.'s spinal implants portfolio consists of a line of products and image-guided surgical solutions to help spinal fusion in degenerative, minimally invasive surgery, and spinal deformity procedures.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
53,786 |
Total Sell Value |
$0 |
$0 |
$0 |
$316,788 |
Total People Sold |
0 |
0 |
0 |
2 |
Total Sell Transactions |
0 |
0 |
0 |
2 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Winge John J. |
Vice President, Sales |
|
2019-06-28 |
4 |
A |
$11.26 |
$11,736 |
D/D |
1,042 |
50,916 |
|
- |
|
Valentine Keith |
Chief Executive Officer |
|
2019-06-28 |
4 |
A |
$11.26 |
$11,195 |
D/D |
994 |
224,985 |
|
- |
|
Lipschultz Tyler |
SVP, Orthobiologics and BD |
|
2019-06-28 |
4 |
A |
$11.26 |
$8,210 |
D/D |
729 |
73,667 |
|
- |
|
Bradley Keith |
Director |
|
2019-05-30 |
4 |
D |
$14.01 |
$6,290 |
D/D |
(449) |
52,391 |
|
- |
|
Gaeta Renee |
Director |
|
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,262 |
13,182 |
|
- |
|
Henneman John B III |
Director |
|
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,262 |
61,970 |
|
- |
|
Bradley Keith |
Director |
|
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,982 |
52,840 |
|
- |
|
Fekete Michael |
Director |
|
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,262 |
55,110 |
|
- |
|
Stephenson Kirtley C. |
Director |
|
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
16,339 |
80,456 |
|
- |
|
Essig Stuart |
Director |
|
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,262 |
422,191 |
|
- |
|
Tzoumakas Kimberly Jo |
Director |
|
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,262 |
13,182 |
|
- |
|
Caruso Richard E |
10% Owner |
|
2019-05-06 |
4 |
S |
$15.17 |
$76,153 |
D/D |
(5,020) |
15,457 |
|
- |
|
Caruso Richard E |
10% Owner |
|
2019-05-06 |
4 |
OE |
$14.15 |
$71,033 |
D/D |
5,020 |
20,477 |
|
- |
|
Bradley Keith |
Director |
|
2019-02-28 |
4 |
D |
$15.34 |
$767 |
D/D |
(50) |
40,858 |
|
- |
|
Gaeta Renee |
Director |
|
2019-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,920 |
5,920 |
|
- |
|
Tzoumakas Kimberly Jo |
Director |
|
2019-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,920 |
5,920 |
|
- |
|
Essig Stuart |
Director |
|
2019-02-15 |
4 |
AS |
$16.08 |
$256,508 |
I/I |
(15,952) |
0 |
|
- |
|
Essig Stuart |
Director |
|
2019-02-14 |
4 |
AS |
$16.09 |
$289,620 |
I/I |
(18,000) |
7,976 |
|
- |
|
Essig Stuart |
Director |
|
2019-02-13 |
4 |
AS |
$16.01 |
$32,020 |
I/I |
(2,000) |
16,976 |
|
- |
|
Essig Stuart |
Director |
|
2019-02-12 |
4 |
AS |
$16.14 |
$326,803 |
I/I |
(20,248) |
17,976 |
|
- |
|
Essig Stuart |
Director |
|
2019-02-11 |
4 |
AS |
$16.01 |
$142,489 |
I/I |
(8,900) |
28,100 |
|
- |
|
Winge John J. |
Vice President, Sales |
|
2019-01-01 |
4 |
D |
$18.24 |
$146,613 |
D/D |
(8,038) |
49,925 |
|
- |
|
Winge John J. |
Vice President, Sales |
|
2019-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,317 |
57,963 |
|
- |
|
Keran Patrick L |
VP, General Counsel |
|
2019-01-01 |
4 |
D |
$18.24 |
$180,831 |
D/D |
(9,914) |
43,671 |
|
- |
|
Keran Patrick L |
VP, General Counsel |
|
2019-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,458 |
53,585 |
|
- |
|
328 Records found
|
|
Page 8 of 14 |
|
|